4.6 Article

Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014-2020

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New Zealand

Suellen A. A. Lyne et al.

Summary: This study investigated the epidemiology and clinical features of giant cell arteritis (GCA) in Canterbury, New Zealand, focusing on extra-cranial large vessel disease. It identified two distinct subsets of the disease - cranial and large vessel disease, suggesting the need for alternative diagnostic and therapeutic approaches for patients with large vessel disease.

FRONTIERS IN MEDICINE (2022)

Letter Rheumatology

Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic

Augustin Lecler et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Ophthalmology

Seasonal variation in biopsy-proven giant cell arteritis in Eastern Denmark from 1990-2018

Elisabeth Bay Konig et al.

Summary: This study investigated the seasonal variation in biopsy-proven GCA cases in eastern Denmark over a 29-year period. The peak occurrence of GCA was found in the 70-79 years age group, with a higher risk of positive biopsy during summer compared to autumn. Although no association was found between weather parameters and biopsy outcomes, future studies pooling all GCA cases worldwide are needed to determine the seasonality in the occurrence of GCA.

ACTA OPHTHALMOLOGICA (2021)

Article Rheumatology

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

Mehrdad Maz et al.

Summary: This study provides evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK), addressing diagnostic testing, treatment, and management. The recommendations cover the use of diagnostic testing, treatments, and surgical interventions in GCA and TAK, with a focus on glucocorticoid-sparing immunosuppressive agents and nonglucocorticoid immunosuppressive agents.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Rheumatology

A meta-analysis of the epidemiology of giant cell arteritis across time and space

Katherine J. Li et al.

Summary: The incidence of GCA varies nearly 3-fold between regions and is highest in Scandinavia but not significantly. Mortality may be improving over time.

ARTHRITIS RESEARCH & THERAPY (2021)

Article Rheumatology

Infections and the risk of incident giant cell arteritis: a population-based, case-control study

Rennie L. Rhee et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Article Medicine, General & Internal

Epidemiology of biopsy-proven giant cell arteritis in South Australia

E. Dunstan et al.

INTERNAL MEDICINE JOURNAL (2014)

Article Ophthalmology

Giant cell arteritis incidence: analysis by season and year in mid-Atlantic United States

Krystian Kisza et al.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)

Editorial Material Rheumatology

Increase in age at onset of giant cell arteritis: a population-based study

Tanaz A. Kermani et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Article Medicine, General & Internal

Giant cell arteritis in northwestern Spain - A 25-year epidemiologic study

Miguel A. Gonzalez-Gay et al.

MEDICINE (2007)